Regulation of Hematopoietic Stem Cell Processing and Transplantation Scott D. Rowley OriginalPaper 01 April 2002 Pages: 237 - 245
Hematopoietic Stem Cell Gene Therapy David W. EmeryTamon NishinoGeorge Stamatoyannopoulos OriginalPaper 01 April 2002 Pages: 228 - 236
Hematopoietic Cell Transplantation as a Form of Immunotherapy Frederick R. Appelbaum OriginalPaper 01 April 2002 Pages: 222 - 227
What is the standard treatment in essential thrombocythemia Tiziano Barbui Current Concepts of the Myeloproliferative Diseases Pages: 311 - 317
Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV Rosemary E. Gale Current Concepts of the Myeloproliferative Diseases Pages: 305 - 310
The therapy of myelofibrosis: Targeting pathogenesis Ruben A. Mesa Current Concepts of the Myeloproliferative Diseases Pages: 296 - 304
Treatment of polycythemia vera with recombinant interferon Richard T. Silver Current Concepts of the Myeloproliferative Diseases Pages: 294 - 295
The present state of advanced practice nursing in hematopoietic stem cell transplantation field in Korea Jung Hee Hong Role of Blood and Marrow Nurses in Field of Transplants Pages: 292 - 292
Research within the field of blood and marrow transplantation nursing: How can it contribute to higher quality of care? Monica C. Fliedner Role of Blood and Marrow Nurses in Field of Transplants Pages: 289 - 291
Role of the Advanced Practice Nurse in blood and marrow transplantation Joyce L. Neumann Role of Blood and Marrow Nurses in Field of Transplants Pages: 288 - 288
Umbilical cord blood for unrelated bone marrow replacement; Asia Bank and Japan cord blood bank network update Hideo MugishimaTuneo TakahashiHidehiko Saito Treatment of Childhood Malignancy Pages: 284 - 286
Designer drugs: New directed therapies for cancer Stephen A. Feig Treatment of Childhood Malignancy Pages: 281 - 283
Childhood acute lymphoblastic Leukemia: Differences in drug resistance between sub-groups of ALL A. J. P. Veerman Treatment of Childhood Malignancy Pages: 280 - 280
Current concepts in treatment of childhood acute lymphoblastic leukemia Ching-Hon Pui Treatment of Childhood Malignancy Pages: 279 - 279
Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children Ann E. WoolfreyMichael A. PulsipherRainer Storb Non-malignant Hematologic Disorders in Childhood Pages: 271 - 277
An approach to the diagnosis and treatment of bleeding disorders in infants Thomas C. Abshire Non-malignant Hematologic Disorders in Childhood Pages: 265 - 270
The quest for quality blood banking program in the new millennium the American way Dae Un Kim Safety Issues in Blood & Blood Products Transfusion Pages: 258 - 262
Pathogen inactivation of blood components: Current status and introduction of an approach using riboflavin as a photosensitizer Frank Corbin Safety Issues in Blood & Blood Products Transfusion Pages: 253 - 257
Human herpesvirus 6 and human herpesvirus 7: Emerging pathogens in transplant patients Duncan A. Clark Safety Issues in Blood & Blood Products Transfusion Pages: 246 - 252
Human T lymphotropic virus type-I and adult T-cell leukemia in Japan Kazunari YamaguchiToshiki Watanabe Safety Issues in Blood & Blood Products Transfusion Pages: 240 - 245
The Myelodysplastic Syndromes: Morphology, risk assessment, and clinical management (2002) John M. BennettPeter A. KouidesStephen J. Forman Myelodysplastic Syndrome Pages: 228 - 238
Important features of myelodysplastic syndrome Wolf-K. HofmannH. Phillip Koeffler Myelodysplastic Syndrome Pages: 222 - 227
Biology and modulation of multidrug resistance (MDR) in hematological malignancies Masao Hirose Chronic Leukemia Pages: 206 - 211
Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation Ahmet H. Elmaagacli Chronic Leukemia Pages: 204 - 205
Clinical and scientific advances in the philadelphia-chromosome negative chronic myeloproliferative disorders Ruben A. Mesa Chronic Leukemia Pages: 193 - 203
Treatment of chronic myeloid leukaemia lessons and challenges John M. Goldman Chronic Leukemia Pages: 189 - 192
New advances in the treatment of acute promyelocytic leukemia Dan Douer The Biology and Treatment of Acute Myeloid Leukemia Pages: 179 - 187
Biologically risk directed therapy for improved trial development and outcomes in patients with AML Robert J. Arceci The Biology and Treatment of Acute Myeloid Leukemia Pages: 178 - 178
Clinical importance of genetic findings in adult AML Clara D. Bloomfield The Biology and Treatment of Acute Myeloid Leukemia Pages: 176 - 177
Aplastic anemia in the orient Seiji Kojima Understanding and Treatment of Acquired Aplastic Anemia Pages: 173 - 174
The relationship of aplastic anemia and PNH Neal S. YoungJaroslaw P. MaciejewskiAkira Miyazato Understanding and Treatment of Acquired Aplastic Anemia Pages: 168 - 172
New advances in the treatment of acquired severe aplastic anaemia Jill Hows Understanding and Treatment of Acquired Aplastic Anemia Pages: 167 - 167
Views on the pathophysiology of aplastic anaemia Edward C. Gordon-SmithJ. C. MarshF. M. Gibson Understanding and Treatment of Acquired Aplastic Anemia Pages: 163 - 166
Minor histocompatibility antigens-targets of graft versus leukemia responses Stanley R. RiddellM. MurataE. H. Warren Histocompatibility in Field of Hematology Pages: 155 - 161
HLA diversity: Detection and impact on unrelated hematopoietic stem cell · donor characterization and selection Carolyn Katovich Hurley Histocompatibility in Field of Hematology Pages: 152 - 154
Current and emerging technology for HLA typing Derek Middleton Histocompatibility in Field of Hematology Pages: 150 - 151
Molecular diagosis of von Willebrand disease Changgeng Ruan Update on Bleeding Disorders Pages: 145 - 148
Management of bleeding disorders by prohemostatic therapy Marcel M. LeviRoel VinkEvert de Jonge Update on Bleeding Disorders Pages: 139 - 144
Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura Han-Mou Tsai Update on Bleeding Disorders Pages: 132 - 138
Idiopathic thrombocytopenic purpura: Pathophysiology and management Yeon S. AhnLawrence L Horstman Update on Bleeding Disorders Pages: 123 - 131
High dose chemotherapy and autologous transplantation for non-Hodgkin’s lymphoma Julie M. Vose Malignant Lymphoma Pages: 115 - 115
Carrier screening and genetic counselling in β-thalassemia Antonio Cao Thalassemia and Hemoglobinopathy Pages: 105 - 113
β-Thalassaemia prototype of a single gene disorder with multiple phenotypes Swee Lay Thein Thalassemia and Hemoglobinopathy Pages: 96 - 104
β-Thalassemia in the Korean population Sung Sup ParkHan-Ik Cho Thalassemia and Hemoglobinopathy Pages: 93 - 95
Thalassemia mutations and their clinical aspects in Japan Yukio Hattori Thalassemia and Hemoglobinopathy Pages: 90 - 92
